免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens

NCT:NCT05886348 · ACTIVE_NOT_RECRUITING

NCT编号NCT05886348
状态ACTIVE_NOT_RECRUITING
开始日期2023-07-31
完成时间2027-05-31
SponsorHOYA Lens Thailand LTD. (INDUSTRY)
First posted
Last updated

简要摘要

The goal of this clinical trial is to test Novel spectacle lenses in myopic children. The main question it aims to answer are: safety and efficacy of the lenses. Participants will be asked to wear spectacles and participate in eye exams and questionnaires. Researchers will compare Novel spectacle lenses and general single vision spectacle lenses to see if the Novel spectacle lenses correct myopic ametropia, slow the progression of myopia and axial elongation.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑